Evaluation of Collagen Gel-Associated Human Nasal Septum-Derived Chondrocytes As a Clinically Applicable Injectable Therapeutic Agent for Cartilage Repair | Zendy

Mi Hyun Lim | Zendy; Jung Ho Jeun | Zendy; Do Hyun Kim | Zendy; Sun Hwa Park | Zendy; Seok Jung Kim | Zendy; Weon Sun Lee | Zendy; Se Hwan Hwang | Zendy; Jung Yeon Lim | Zendy; Sung Won Kim | Zendy

Open Access

Evaluation of Collagen Gel-Associated Human Nasal Septum-Derived Chondrocytes As a Clinically Applicable Injectable Therapeutic Agent for Cartilage Repair

Author(s) -

Mi Hyun Lim,

Jung Ho Jeun,

Do Hyun Kim,

Sun Hwa Park,

Seok Jung Kim,

Weon Sun Lee,

Se Hwan Hwang,

Jung Yeon Lim,

Sung Won Kim

Publication year - 2020

Publication title -

tissue engineering and regenerative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.719

H-Index - 23

eISSN - 2212-5469

pISSN - 1738-2696

DOI - 10.1007/s13770-020-00261-9

Subject(s) - cartilage , regeneration (biology) , chondrocyte , nasal septum , chemistry , tissue engineering , chondrogenesis , pathology , medicine , microbiology and biotechnology , biomedical engineering , surgery , anatomy , biology , nose

Articular cartilage injury has a poor repair ability and limited regeneration capacity with therapy based on articular chondrocytes (ACs) implantation. Here, we validated the hypothesis that human nasal septum-derived chondrocytes (hNCs) are potent therapeutic agents for clinical use in cartilage tissue engineering using an injectable hydrogel, type I collagen (COL1).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research